Challenges Emerge from Low NASH Awareness
Addressing the current hurdles and potential solutions in nonalcoholic steatohepatitis awareness and clinical trial enrollment.
Low Awareness of NASH Presents Significant Clinical Trial Challenges
Cathleen Dohrn, Senior Scientific Director for Continuum Clinical, describes the momentous challenges in clinical trials presented by low awareness of nonalcoholic steatohepatitis.
Considering Sex as a Variable in Clinical Trials
A sex-bias that significantly impacts the advancement of women’s health exists in both preclinical and clinical research.
2 Clarke Drive Cranbury, NJ 08512